Clinical trial
Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee…
NCT00371683 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00371683 |
|---|---|
| Title | Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery |
| Official title | A Phase 3 Randomized, Double-Blind Active-Controlled (Enoxaparin), Parallel-Group, Multi-Center Study to Evaluate the Safety and Efficacy of Oral Apixaban in Subjects Undergoing Elective Total Knee Replacement Surgery |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Deep Vein Thrombosis, Pulmonary Embolism |
| Intervention type | Drug |
| Interventions | Enoxaparin + Placebo, Apixaban + Placebo |
| Enrollment | 3,608 |
| Start date | Nov 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Sep 4, 2006 |
| Last update posted | Dec 30, 2015 |
| Countries | Argentina, Australia, Brazil, Canada, Denmark, Hungary, Israel, Mexico, Poland, Russia, Sweden, Turkey (Türkiye) and 1 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: